PRNP and prion disease: As compared with uninfected controls, terminal control mice (both saline and control ASO–treated) showed pathological changes consistent with advanced prion disease, such as granular PrP deposits, spongiform vacuolation, astrogliosis, and elevated PK-resistant PrP levels (Figure 4).